Finance ❯ Investments ❯ Stock Analysis

Market Reactions

Eos Energy Enterprises Price Volatility Pharmaceutical Stocks GitLab Stock Earnings Guidance Profit Forecasts Earnings Surprises Investor Sentiment Analyst Estimates

Alumis Shares Plunge After Phase 2b Lupus Trial Misses Primary Goal

A strong prespecified interferon‑high (IFNGS‑high) subgroup response gives the company a path to pursue a biomarker‑focused Phase 3.

Dynatrace Beats Q4 and Tops $2 Billion ARR as Shares Sink on Slower Growth Outlook

Eos Energy Soars on Q1 Revenue Guide, Record Output and Line 2 Milestone

GitLab Shares Drop After FY27 Outlook Misses Wall Street Targets

Analysts Defend Broadcom After Post‑Earnings Slide as UBS Raises Target